Article Details

Precision Medicine Group Raises $275M to Support Biomarker-Guided Drug Development

Retrieved on: 2017-12-21 10:26:15

Tags for this article:

Click the tags to see associated articles and topics

Precision Medicine Group Raises $275M to Support Biomarker-Guided Drug Development. View article details on hiswai:

Excerpt

<div>... experts focused on biomarker-guided drug development has raised $275 million in funding led by Berkshire Partners and TPG Growth and also includes significant participation from Precision's co-founders and management team as well as original investors <b>Oak Investment Partners</b> and J.H. Whitney.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo